The FDA approved rifaximin, a non-absorbed antibiotic that remains within the body’s gastrointestinal system, for traveller’s diarrhea. This is in contrast to most other antibiotics which are spread throughout the body. Cipro or Bactrim are medications that are currently used.
A review article has suggested that this therapy may become the treatment of choice once routinely available.
